Abstract: In particular, this invention refers to a composition comprising a probiotic combination comprising: a) at least one strain of the genus Lactobacillus selected from the species Lactobacillus plantarum; and c) at least one strain belonging to the genus Bifidobacterium selected from the species Bifidobacterium lactis, Bifidobacterium longum, Bifidobacterium infantis; wherein said composition is for use in a method for the prevention and/or treatment of chronic inflammatory bowel disease (Inflammatory Bowel Disease IBD).

Abstract: Disclosed are compositions including a probiotic combination including a strain belonging to the Lactobacillus reuteri species in association with a strain belonging to the Bifidobacterium genus selected from the species: Bifidobacterium breve or Bifidobacterium lactis. These compositions are useful in the prevention and/or treatment of acute or chronic stress-related pathological conditions selected from the group including impairment of cognitive function, insomnia, anxiety, baby blues and post-partum depression, menopausal depression, generalized anxiety disorder, major depressive disorder, panic attacks, attention deficit disorder or combinations thereof. Methods of treatment are also disclosed.

Abstract: Disclosed are probiotic compositions including Lactobacillus plantarum, Lactobacillus rhamnosus and Lactobacillus reuteri, as well as methods for the prevention and/or treatment of skin diseases and/or disorders using such compositions.

Abstract: Disclosed are probiotic compositions including: one or more strains belonging to the genus Lactobacillus selected from the species: Lactobacillus plantarum and Lactobacillus acidophilus; and one or more strains belonging to the genus Bifidobacterium selected from the species: Bifidobacterium lactis, Bifidobacterium infantis and Bifidobacterium longum. The compositions include: at least one strain of Lactobacillus plantarum and at least one strain of Bifidobacterium lactis; and at least two strains belonging to the genus Lactobacillus or to the genus Bifidobacterium as defined above. Also disclosed are methods to modulate immune systems using such compositions.

Abstract: Disclosed are methods of using probiotic compositions containing Lactobacillus plantarum, Lactobacillus rhamnosus, and Bifidobacterium animalis subsp. lactis. to prevent and/or treat urogenital infections in women by oral administration.

Abstract: Disclosed are methods of using probiotic compositions containing Lactobacillus plantarum, Lactobacillus rhamnosus, and Bifidobacterium animalis subsp. lactis. to prevent and/or treat urogenital infections in women by oral administration.

Abstract: Disclosed are probiotic compositions containing Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium animalis subsp. lactis. Such compositions are useful to prevent and/or treat urogenital infections in women by oral administration.

Abstract: The invention relates generally to intradermal, transdermal, and/or transmembrane delivery of biologically active substances in the epidermis and/or through the skin, sub-dermal tissues, blood vessels and cellular membranes without causing damage to the cellular surface, tissue or membrane. The biologically active substances may have a molecular weight no less than about 5.8 kDa to about 2,500 kDa, such as Hyaluronic Acid (HA). The biologically active substances may be deposited in a dermal patch containing a red algae polysaccharide-based matrix, wherein the red algae polysaccharide is an extract of Chondrus crispus at 2% by weight of the dermal patch. The invention provides systems and methods for enhanced intradermal, transdermal, and/or transmembrane delivery of such biologically active substances using pulsed incoherent light. The invention further provides a device for the application of the pulsed incoherent light to cellular surfaces and membranes using those compositions and methods.